Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Key International (BKYI) Income from Continuing Operations (2016 - 2025)

Bio Key International (BKYI) has disclosed Income from Continuing Operations for 16 consecutive years, with 964849.0 as the latest value for Q3 2025.

  • Quarterly Income from Continuing Operations fell 30.57% to 964849.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 4253287.0 through Sep 2025, up 19.58% year-over-year, with the annual reading at 4300692.0 for FY2024, 49.53% up from the prior year.
  • Income from Continuing Operations hit 964849.0 in Q3 2025 for Bio Key International, up from 1167396.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 510285.0 in Q1 2024 to a low of 6789034.0 in Q4 2022.
  • Historically, Income from Continuing Operations has averaged 1713526.47 across 5 years, with a median of 1384497.0 in 2024.
  • Biggest five-year swings in Income from Continuing Operations: soared 76.36% in 2021 and later crashed 239.62% in 2022.
  • Year by year, Income from Continuing Operations stood at 1999020.0 in 2021, then plummeted by 239.62% to 6789034.0 in 2022, then skyrocketed by 65.05% to 2372814.0 in 2023, then skyrocketed by 41.65% to 1384497.0 in 2024, then surged by 30.31% to 964849.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for BKYI at 964849.0 in Q3 2025, 1167396.0 in Q2 2025, and 736545.0 in Q1 2025.